Thank you for sharing!

Your article was successfully shared with the contacts you provided.
While there is speculation of where CBD regulations could be headed, no one knows for sure and it will largely depend on who replaces Gottlieb as the head of the FDA. (Photo: Shutterstock)

U.S. Food and Drug Administration Commissioner Dr. Scott Gottlieb’s impending departure may push back long-awaited regulations on hemp and CBD, according to experts involved in those industries.

Rick Weissman, the president of hemp products maker High Falls Extracts, said Gottlieb, who announced Tuesday he will leave the FDA at the end of the month, supported hemp and CBD regulatory efforts.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.